CEO Siddharth Mittal believes Biocon’s existing portfolio, including liraglutide, gives it an edge in a highly competitive ...
Zacks Investment Research on MSN
Here's Why McKesson (MCK) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
HealthDay on MSN
Diabetes drug appears to mitigate benefits of daily walks
Metformin appears to blunt improvements in blood pressure, fitness and blood sugar control that normally come from regular ...
Generic drug giant Sandoz expects unbranded versions of Novo Nordisk's popular diabetes drug Ozempic to launch in Canada by the second quarter next year after a key patent expires, its CEO said on ...
Sitaram, 43, believes that tending to her gut health with tasty and balanced diet is the most crucial step of her skincare ...
Supported by nutrition experts, the Non-UPF seal highlights foods without additives, colorings, or ultra-processed shortcuts ...
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Generic drugmaker Sandoz expects unbranded versions of Novo Nordisk's blockbuster diabetes drug Ozempic to launch in Canada by the end of June next ...
News Medical on MSN
Extended use of anti-clotting drugs reduces risk of recurrent blood clots
Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to ...
Experts say FDA officials and doctors should treat hormone therapy like any other drug that has both benefits and risks, and ...
Adults hospitalized for acute COPD exacerbation faced elevated odds for all-cause mortality and ICU admission if they had end-stage renal disease and were on dialysis, according to data presented at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results